|
|
Cryolife, Inc. - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for Cryolife, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Cryolife, Inc.. The Group's principal activities are to develop and commercialize biomaterials, implantable medical devices. it also preserve and distribute human tissues for cardiovascular and vascular transplant applications. The Group operates in two segments: Implantable Medical Devices and Preservation Services. The Implantable medical devices segment includes the sales of BioGlue and bioprosthetic devices, including stentless porcine heart valves and SynerGraft processed bovine vascular grafts. The Preservation Services segment includes the preservation of cardiac, vascular, and orthopaedic allograft tissues. The Group's products are marketed in the United States, Europe, the Middle East, Canada, Australia and Asia.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|